ALPS Medical Breakthroughs ETF
SBIO
Closed
$53.55
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
SBIO was created on 2014-12-31 by ALPS. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 156.14m in AUM and 84 holdings. SBIO tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.
Company
ALPS
Asset class
Equity
Inception date
2014
Investment segment
Health Care
ISIN
US00162Q5936
Website
Key stats
Open
$54.34
Volume
10.26K
AUM
$152.60M
Prev. close
$53.50
Expense ratio
0.50%
P/E
0.00
$52.55
Day’s Range
$54.34
$47.63
52W Range
$57.77
What’s in the fund
2
Total sectors
Health Care
96.39%
Others
3.61%
Returns
Performance
_
Difference
_
ALPS Medical Breakthroughs ETF
Dec
26
Dividends
The last payment date was Dec 26, 2024
Div. per Share
$1.17
Div. Yield
2.19%
Div. Growth YoY
1,551.37%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply